Reach Us +441730450007
Treating Parkinson Disease with Adult Stem Cells | OMICS International | Abstract
ISSN: 2329-6895

Journal of Neurological Disorders
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Review Article

Treating Parkinson Disease with Adult Stem Cells

Henry E Young1*, Lee Hyer2, Asa C Black Jr3 and Joe Sam Robinson Jr4
1Professor, Regeneration Technologies, Macon, USA
2Professor, Georgia Neurological Institute, Macon, USA
3Professor, Memorial General Hospital-University of South Carolina Medical School, Greenville, USA
4Neurosurgeon, Georgia Neurological Institute, Macon, USA
Corresponding Author : Henry E Young
Regeneration Technologies
778-B Mulberry Street, Macon, GA 31201, USA
Tel: 478-319-1983
E-mail: [email protected]
Received February 15, 2013; Accepted June 20, 2013; Published June 22, 2013
Citation: Young HE, Hyer L, Black Jr AC, Robinson Jr JS (2013) Treating Parkinson Disease with Adult Stem Cells. J Neurol Disord 1:121. doi: 10.4172/2329-6895.1000121
Copyright: © 2013 Young HE, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google


Parkinson disease affects ~2% of all people 70 years of age and older. People with Parkinson disease exhibit excessive shaking (tremors) at rest, loss of mental function, loss of involuntary function, and psychiatric problems. A proposed experimental cure for Parkinson disease is the transplantation of healthy nerve cells into the brain. It has been proposed that these nerve cells be taken from either aborted fetuses or derived from embryonic stem cells. Due to ethical and moral issues that proposal will probably not become a reality. Endogenous adult totipotent stem cells and adult pluripotent stem cells are very similar to embryonic stem cells. These primitive adult stem cells will form neurons, glia, skin, muscle, fat, cartilage, bone, blood vessels, blood cells, liver cells and pancreas cells under the appropriate inductive conditions. The current report proposes the use of adult totipotent stem cells for the treatment of Parkinson disease. As a test of this proposal, adult totipotent stem cells were utilized in a bedside clinical autologous phase-0 efficacy trial in adult humans with Parkinson disease. The results from this study suggested an efficacious response utilizing adult totipotent stem cells as a treatment modality for Parkinson disease.


Recommended Conferences
Share This Page